Total synthesis of novel antibiotics pyloricidin A, B and C and their application in the study of pyloricidin derivatives

被引:10
作者
Hasuoka, A
Nishikimi, Y
Nakayama, Y
Kamiyama, K
Nakao, M
Miyagawa, K
Nishimura, O
Fujino, M
机构
[1] Takeda Chem Ind Ltd, Div Pharmaceut Res, Med Chem Res Labs 1, Yodogawa Ku, Osaka 5328686, Japan
[2] Takeda Chem Ind Ltd, Mkt Div, Vaccine Grp, Chuo Ku, Osaka 5408645, Japan
[3] Takeda Chem Ind Ltd, Div Pharmaceut Res, Pharmaceut Discovery Ctr, Yodogawa Ku, Osaka 5328686, Japan
[4] Takeda Chem Ind Ltd, Div Pharmaceut Res, Tsukuba, Ibaraki 3004293, Japan
[5] Takeda Chem Ind Ltd, Chuo Ku, Osaka 5328645, Japan
关键词
D O I
10.7164/antibiotics.55.191
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The novel natural antibiotics pyloricidin A, B and C, which possess potent and highly selective anti-Helicobacter pylori activity, were synthesized from D-galactosamine as a chiral template for the common (2S,3R,4R,5S)-5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety. The synthetic strategy, using 2-amino-2-deoxyuronic acid derivatives as key intermediates, was also useful to prepare a series of derivatives modified at the beta-D-phenylalanine and with altered stereochemistry on the 5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety. From the drastic decrease of their anti-H. pylori activity, it was clear that the beta-D-phenylalanine part and the stereochemistry of the 5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety were significant for the activity.
引用
收藏
页码:191 / 203
页数:13
相关论文
共 20 条
[11]  
MANNES GA, 1993, EUR J GASTROEN HEPAT, V5, P145
[12]   Pyloricidins, novel anti-Helicobacter pylori antibiotics produced by Bacillus sp.: II.: Isolation and structure elucidation [J].
Nagano, Y ;
Ikedo, K ;
Fujishima, A ;
Izawa, M ;
Tsubotani, S ;
Nishimura, O ;
Fujino, M .
JOURNAL OF ANTIBIOTICS, 2001, 54 (11) :934-947
[13]   Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori [J].
Nakao, M ;
Malfertheiner, P .
HELICOBACTER, 1998, 3 (01) :21-27
[14]   Pyloricidins, novel anti-Helicobacter pylori antibiotics produced by Bacillus sp.: I.: Taxonomy, fermentation and biological activity [J].
Nakao, M ;
Miyagawa, K ;
Nakano, Y ;
Sakane, T ;
Tada, M ;
Nishimura, O ;
Fujino, M .
JOURNAL OF ANTIBIOTICS, 2001, 54 (11) :926-933
[15]   HIGH-FIELD FT NMR APPLICATION OF MOSHER METHOD - THE ABSOLUTE-CONFIGURATIONS OF MARINE TERPENOIDS [J].
OHTANI, I ;
KUSUMI, T ;
KASHMAN, Y ;
KAKISAWA, H .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (11) :4092-4096
[16]   GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION [J].
TALLEY, NJ ;
ZINSMEISTER, AR ;
WEAVER, A ;
DIMAGNO, EP ;
CARPENTER, HA ;
PEREZPEREZ, GI ;
BLASER, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (23) :1734-1739
[17]  
WARREN JR, 1983, LANCET, V1, P1273
[18]   Helicobacter pylori infection induces gastric cancer in Mongolian gerbils [J].
Watanabe, T ;
Tada, M ;
Nagai, H ;
Sasaki, S ;
Nakao, M .
GASTROENTEROLOGY, 1998, 115 (03) :642-648
[19]   INVITRO SUSCEPTIBILITY OF HELICOBACTER-PYLORI TO THE NEW ORAL CEPHALOSPORINS CEFPODOXIME, CEFTIBUTEN AND CEFIXIME [J].
WESTBLOM, TU ;
GUDIPATI, S ;
MIDKIFF, BR .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (09) :691-693
[20]  
YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65